Deep Vein Thrombosis And Peripheral Thrombphlebitis Flashcards

1
Q

DVT=

A

🔸Blood clot that form in a deep vein in the body , most of the clots occur in the lower leg or thigh
🔸often resulting in a potentially life threatening emboli in the lungs or debilitating valvular dysfunction or chronic leg swelling (post thrombotic syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

3 factors that are critically important in the development of venous thrombosis:
🔸these factors named VIRCHOW TRIAD

A

(1) venous stasis
(2) hypercoagulability
(3) vein damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Etiology for DVT:

A

1.major surgeries ( hip or knee replacement, pelvic surger)
2.fractures
3.immobility
4.cancer+- chemotherapy
🔸risk factors can be subdivided by duration:
-Transient ( leg fracture , surgery, pregnancy, use if OC)
-long term ( conginetal antithrombin deficiency, cancer)
*distal DVTs more frequently related to transient situations while proximal to chronic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Clinical manifestations:

A

1)spontaneous pain
2)induced pain ( walking, compression, positive homan’s sign )
3)edema : phlegmasia alba dolnes (painful white edema, milk leg, total occlusion of deep ileofemoral veinous system ), phlegmasia cerulea dolens ( painful blue appearance of the leg , occurs due to massive thrombosis involving major and collateral vein of the leg )
___________
Signs and symptoms:
Calf or thigh pain , tenderness , swelling, or superficial venous dilation ( not specific for DVT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Imaging diagnosis DVT=

A

▪️compression venous ultrasonography+- doppler
▪️magnetic resonance venography ( high specificity and sensitivity for proximal DVT), EXPENSIVE
▪️contrast venography ( is the reference standard )
1ST LINE IMAGING

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Lab findings of DVT:

A

▪️D-dimer : elevated in plasma
*exclude VTE when levels are not raised
DDX: sepsis , pregnancy, surgery and cardiac/renal failure ( also can cause elevated D-dimer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

The wells score :

A

Is a number that reflects the risk of developing DVT
3 level WELLS SCORE:
▪️low risk <2
▪️intermediate 2-6
▪️high risk >6
2 level WELLS SCORE:
▪️unlikely <1
▪️likely>2
*PE unlikely 0-4
*PE likely >4
———————
*active cancer 1️⃣
*Paralysis, paresis or plaster immobalization of the lower extremitiy 1️⃣
*recent bedridden for 3 days or more , major surgery within the prev 12 weeks1️⃣
*localized tenderness along the distribution of DV system1️⃣
*entire leg swelling1️⃣
*calf swelling at least 3cm larger than that one asymptomatic leg 1️⃣
*pitting edema confined to the symptomatic leg1️⃣
*collateral superficial veins1️⃣
*prev documented DVT1️⃣
*alternative diagnosis at least as likely as DVT -2️⃣
*

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Differential diagnosis with DVT:

A
  • muscle strain
  • direct twisting injury to leg
  • leg swelling in paralyzed limb
  • lymphaginitis, lymphatic obstruction
  • venous reflux
  • muscle tear
  • baker cyst
  • cellulitis
  • internal abnormality of the knee
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Treatment :

A

✅anticoagulation (standard therapy): 🔹oral direct thrombin and factor xa inhibitors:
RIVAROXABAN= 15 mg twice daily for 3 wks followed by 20 mg/day
APIXABAN=10mg twice a day for 1 wk followed by 5 mg 2/day
🔹heparin:
unfractionated heparin(iv)= must be given as a continuous infusion, aPTT should be monitored ( iv bolus 5000 IU, iv infusion 15,000 IU over 12 hrs)
low mulecular weight heparin= sc( once or twice daily)
DALTEPARIN
ENOXAPARIN
NADROPARIN
TINZAPARIN
🔸no aPTT needed, dosage depends on patients weight
* does not lyse the clot, prevent clot formation/ extension
✅thrombolysis /thrombectomy - mechanical thrombus removal alone is not successful and needs adjuvant thrombolytic therapy
OTHER ANTICOAGULANTS:
🔹acenocumarol initiate 4-6mg/day
🔹warfarine initiate 5-10mg/day
*they inhibit the production of clotting factors 2,7,9,10,
The goal of INR ratio is 2-3
🔹DOAC= DABIGATRAN, APIXABAN, RIVAROXABAN, EDOXABAN
✅vena cava filter
✅compression= elastic compression stockings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Oral direct thrombin and factor Xa inhibitors:

A

✅rivaroxaban: 15 mg twice daily for 3 weeks followed by 20

✅apixaban: 10mg twice daily for 7 days followed by 5 mg twice daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Administration of UF heparin:

A

1) Iv bolus 5,000 IU
2) iv infusion 15,000 IU over 12 hrs
3) check aPTT ratio

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Low molecular weight Heparin:

A
✅dalteparin
✅enoxaparin
✅nadroparin
✅tinzaparin
✅fondaparinux
*sc (once or twice daily)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Antivitamin K anticoagulants:

A

1)acenocumarol initiate 4-6 mg/day
2)warfarine initiate 5-10mg/day
▪️Mechanism: inhibit the production of clotting factors II, VII, IX , X

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Transition to oral treatment ;(DOAC):

A

Dabigatran: 150 mg twice daily
Apixaban 5mg twice daily
Rivaroxaban 20 mg/ day
Edoxaban 60mg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Side effects of anticoagulants :

A
Bleedings 
Major bleeding( intracranial, GI or retroperitoneal) leading to hospitalization, transfusion or death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

DVT prevention:

A
🔸surgery 
🔸major trauma 
🔸prolonged bedrest or 🔸immobilization >72hrs
🔸 previous episodes of VTE
🔸 presence of malignant disease 
🔸paralysis 
🔸morbid obesity 
🔸increasing age 
✅mechanical prophylaxis 
✅low dose fractionated heparin 
✅low dose oral DOAC
17
Q

Pulmonary Embolism=

A

Describes the blockage of a pulmonary artery or one of its branches by a blood clot or foreign material
-pulmonary thromboembolism is not a disease in and of itself, rather its a complication of underlying venous thrombosis

18
Q

Clinical manifestation of PE:

A
▪️abrupt onset of pleuritic chest pain
▪️shortness of breath 
▪️hemoptysis 
▪️fever 
▪️syncope and seizures
▪️cardiogenic shock 
▪️new onset atrial fibrillation
▪️tachycardia >100 bpm, cyanosis , hypoxemia 
▪️distended jugular veins ( right HF)
▪️pulmonary rales
19
Q

Paraclinical investigations PE:

A
🔸D-dimer testing in plasma
🔸thoracic radiography
🔸ECG 
🔸echocardiography 
🔸CT pulmonary angiography 
🔸MRI
🔸pulmonary angiography( GOLD DTANDARD) 
🔸ECG, acute cor pulmonary
🔸echocardiography ( dilated R atrium and ventricle , moderate tricuspid regurgitation , elevated PA pressure <55mmhg
20
Q

Treatment of PE:

A
✅medical treatment 
-fibrinolytic therapy 
-anticoagulation therapy 
✅mechanical reperfusion 
-percutaneous catheter embolectomy 
✅surgical reperfusion
21
Q

Fibrinolytic therapy in PE:

A

-should be used in pts with acute PE associated with hT (systolic<90mmHg)
✅streptokinase (250,000 IU as loading dose over 30 min)
✅tissue plasminogen activator (actilyse) 100mg over 2 hrs